文献速递认知障碍与痴呆脑血管病

中年血管风险与AD生物标志物对后续认知下降的独立关联

Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline.
PubMed 文献 · Neurology · 2020-09-28

该观察性队列研究纳入168例基线认知正常、平均56.4岁的中年人,评估血管风险评分与脑脊液AD生物标志物对认知下降的独立或协同作用。结果显示血管风险评分与AD生物标志物各自独立且叠加地与认知下降相关,血管风险与脑脊液Aβ1-42、t-tau、p-tau水平或变化无关。

要点

  • 中年血管风险与AD生物标志物对认知下降的作用相互独立且叠加
  • 血管风险评分与脑脊液AD病理标志物水平及变化无关
  • 识别认知下降高危个体需同时考虑血管风险与AD病理

核心结论

  • 中年血管风险与AD生物标志物独立且叠加地与后续认知下降相关,无协同效应。
  • 血管风险与脑脊液Aβ1-42、t-tau、p-tau水平或变化率无关。

研究设计与样本

  • 观察性队列研究,基线纳入168例认知正常、平均年龄56.4岁(SD 10.9)的参与者。
  • 血管风险用复合评分(高血压、高胆固醇血症、糖尿病、当前吸烟、肥胖的有无)量化。
  • 脑脊液Aβ1-42、t-tau、p-tau用于划分高低AD生物标志物组。
  • 线性混合效应模型分析认知复合评分变化(平均随访13.9年)和脑脊液生物标志物变化(平均随访4.2年)。

主要发现

  • 血管风险评分与认知下降独立相关(估计值-0.022,95%CI -0.043至-0.002,p=0.03)。
  • AD生物标志物与认知下降独立相关(估计值-0.060,95%CI -0.096至-0.024,p=0.001)。
  • 未发现血管风险评分与AD生物标志物对认知下降的协同关系。
  • 血管风险评分与脑脊液Aβ1-42、t-tau、p-tau水平及变化率无关。

临床怎么用

  • 中年期评估血管风险与AD生物标志物有助于识别认知下降高危的认知正常个体。
  • 血管风险与AD病理可能沿独立通路影响认知,需综合管理多重风险因素。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether vascular risk and Alzheimer disease (AD) biomarkers have independent or synergistic effects on cognitive decline and whether vascular risk is associated with the accumulation of AD pathology as measured by change in biomarkers over time. METHODS: At baseline, participants (n = 168) were cognitively normal and primarily middle-aged (mean 56.4 years, SD 10.9 years) and had both vascular risk factor status and proximal CSF biomarkers available. Baseline vascular risk was quantified with a composite vascular risk score reflecting the presence or absence of hypertension, hypercholesterolemia, diabetes, current smoking, and obesity. CSF biomarkers of β-amyloid (Aβ)1-42, total tau (t-tau), and phosphorylated tau (p-tau) were used to create dichotomous high and low AD biomarker groups (based on Aβ1-42 and tau). Linear mixed-effects models were used to examine change in a cognitive composite score (mean follow-up 13.9 years) and change in CSF biomarkers (mean follow-up 4.2 years). RESULTS: There was no evidence of a synergistic relationship between the vascular risk score and CSF AD biomarkers and cognitive decline. Instead, the vascular risk score (estimate -0.022, 95% confidence interval [CI] -0.043 to -0.002, p = 0.03) and AD biomarkers (estimate -0.060, 95% CI -0.096 to -0.024, p = 0.001) were independently and additively associated with cognitive decline. In addition, the vascular risk score was unrelated to levels of or rate of change in CSF Aβ1-42, t-tau, or p-tau. CONCLUSIONS: The results of this observational cohort study suggest that vascular risk and biomarkers of AD pathology, when measured in midlife, act along independent pathways and underscore the importance of accounting for multiple risk factors for identifying cognitively normal individuals at the greatest risk of cognitive decline.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Pettigrew C, Soldan A, Wang J, et al. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology. 2020. PMID: 32989109. doi:10.1212/WNL.0000000000010946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。